Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,290 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Alteration of serum markers in COVID-19 and implications on mortality.
Liu D, Li R, Yu R, Wang Y, Feng X, Yuan Y, Wang S, Zeng S, Gao Y, Xu S, Li H, Jiao X, Chi J, Yu Y, Song C, Jin N, Cui P, Liu J, Zheng X, Gong W, Liu X, Cai G, Song J, Kwan SY, Desai A, Li C, Gao Q. Liu D, et al. Among authors: jin n. Clin Transl Med. 2020 Jul;10(3):e119. doi: 10.1002/ctm2.119. Epub 2020 Jul 21. Clin Transl Med. 2020. PMID: 32696591 Free PMC article. No abstract available.
Risk factors for developing into critical COVID-19 patients in Wuhan, China: A multicenter, retrospective, cohort study.
Liu D, Cui P, Zeng S, Wang S, Feng X, Xu S, Li R, Gao Y, Yu R, Wang Y, Yuan Y, Li H, Jiao X, Chi J, Liu J, Yu Y, Zheng X, Song C, Jin N, Gong W, Liu X, Cai G, Li C, Gao Q. Liu D, et al. Among authors: jin n. EClinicalMedicine. 2020 Aug;25:100471. doi: 10.1016/j.eclinm.2020.100471. Epub 2020 Jul 30. EClinicalMedicine. 2020. PMID: 32840491 Free PMC article.
Machine learning based early warning system enables accurate mortality risk prediction for COVID-19.
Gao Y, Cai GY, Fang W, Li HY, Wang SY, Chen L, Yu Y, Liu D, Xu S, Cui PF, Zeng SQ, Feng XX, Yu RD, Wang Y, Yuan Y, Jiao XF, Chi JH, Liu JH, Li RY, Zheng X, Song CY, Jin N, Gong WJ, Liu XY, Huang L, Tian X, Li L, Xing H, Ma D, Li CR, Ye F, Gao QL. Gao Y, et al. Among authors: jin n. Nat Commun. 2020 Oct 6;11(1):5033. doi: 10.1038/s41467-020-18684-2. Nat Commun. 2020. PMID: 33024092 Free PMC article.
Macrophages facilitate tumor cell PD-L1 expression via an IL-1β-centered loop to attenuate immune checkpoint blockade.
Xu C, Xia Y, Zhang BW, Drokow EK, Li HY, Xu S, Wang Z, Wang SY, Jin P, Fang T, Xiong XM, Huang P, Jin N, Tan JH, Zhong Q, Chen YX, Zhang Q, Fang Y, Ye F, Gao QL. Xu C, et al. Among authors: jin p, jin n. MedComm (2020). 2023 Mar 30;4(2):e242. doi: 10.1002/mco2.242. eCollection 2023 Apr. MedComm (2020). 2023. PMID: 37009412 Free PMC article.
Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors.
Luo Y, Xia Y, Liu D, Li X, Li H, Liu J, Zhou D, Dong Y, Li X, Qian Y, Xu C, Tao K, Li G, Pan W, Zhong Q, Liu X, Xu S, Wang Z, Liu R, Zhang W, Shan W, Fang T, Wang S, Peng Z, Jin P, Jin N, Shi S, Chen Y, Wang M, Jiao X, Luo M, Gong W, Wang Y, Yao Y, Zhao Y, Huang X, Ji X, He Z, Zhao G, Liu R, Wu M, Chen G, Hong L; COCPO Consortium; Ma D, Fang Y, Liang H, Gao Q. Luo Y, et al. Among authors: jin p, jin n. Cell. 2024 Sep 5;187(18):4905-4925.e24. doi: 10.1016/j.cell.2024.06.013. Epub 2024 Jul 5. Cell. 2024. PMID: 38971151 Free article. Clinical Trial.
PARP inhibitors enhance antitumor immune responses by triggering pyroptosis via TNF-caspase 8-GSDMD/E axis in ovarian cancer.
Xia Y, Huang P, Qian YY, Wang Z, Jin N, Li X, Pan W, Wang SY, Jin P, Drokow EK, Li X, Zhang Q, Zhang Z, Li P, Fang Y, Yang XP, Han Z, Gao QL. Xia Y, et al. Among authors: jin p, jin n. J Immunother Cancer. 2024 Oct 4;12(10):e009032. doi: 10.1136/jitc-2024-009032. J Immunother Cancer. 2024. PMID: 39366751 Free PMC article. Clinical Trial.
1,290 results